BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yaya I, Marcellin F, Costa M, Morlat P, Protopopescu C, Pialoux G, Santos ME, Wittkop L, Esterle L, Gervais A, Sogni P, Salmon-Ceron D, Carrieri MP; ANRS CO13-HEPAVIH Cohort Study Group. Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort). Nutrients 2018;10:E705. [PMID: 29857547 DOI: 10.3390/nu10060705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Cornelis MC. The Impact of Caffeine and Coffee on Human Health. Nutrients 2019;11:E416. [PMID: 30781466 DOI: 10.3390/nu11020416] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Llamosas-Falcón L, Shield KD, Gelovany M, Hasan OSM, Manthey J, Monteiro M, Walsh N, Rehm J. Impact of alcohol on the progression of HCV-related liver disease: A systematic review and meta-analysis. J Hepatol 2021;75:536-46. [PMID: 33892007 DOI: 10.1016/j.jhep.2021.04.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sunyer-Caldú A, Diaz-Cruz MS. Development of a QuEChERS-based method for the analysis of pharmaceuticals and personal care products in lettuces grown in field-scale agricultural plots irrigated with reclaimed water. Talanta 2021;230:122302. [PMID: 33934770 DOI: 10.1016/j.talanta.2021.122302] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ikram M, Park TJ, Ali T, Kim MO. Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer's and Parkinson's Disease: Insight into the Role of Nrf-2 and A2AR Signaling. Antioxidants (Basel) 2020;9:E902. [PMID: 32971922 DOI: 10.3390/antiox9090902] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
5 Vargas-Pozada EE, Muriel P. Herbal medicines for the liver: from bench to bedside. Eur J Gastroenterol Hepatol 2020;32:148-58. [PMID: 31895207 DOI: 10.1097/MEG.0000000000001485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Nehlig A. Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update. Nutrients 2022;14:399. [PMID: 35057580 DOI: 10.3390/nu14020399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lyu H, Tang H, Liang Y, Huang S, Wang Y, Huang W, Zhou Y. Alcohol Consumption and Risk of Liver Fibrosis in People Living With HIV: A Systematic Review and Meta-Analysis. Front Immunol 2022;13:841314. [DOI: 10.3389/fimmu.2022.841314] [Reference Citation Analysis]
8 Elnagdy M, Barve S, McClain C, Gobejishvili L. cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease. Biomolecules 2020;10:E1433. [PMID: 33050657 DOI: 10.3390/biom10101433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Antwerpes S, Protopopescu C, Morlat P, Marcellin F, Wittkop L, Di Beo V, Salmon-Céron D, Sogni P, Michel L, Carrieri MP, The Anrs Co Hepavih Study Group. Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH). Nutrients 2020;12:E2532. [PMID: 32825538 DOI: 10.3390/nu12092532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Juan C, de Simone G, Sagratini G, Caprioli G, Mañes J, Juan-García A. Reducing the effect of beauvericin on neuroblastoma SH-SY5Y cell line by natural products. Toxicon 2020;188:164-71. [PMID: 33164869 DOI: 10.1016/j.toxicon.2020.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Juan-García A, Caprioli G, Sagratini G, Mañes J, Juan C. Coffee Silverskin and Spent Coffee Suitable as Neuroprotectors against Cell Death by Beauvericin and α-Zearalenol: Evaluating Strategies of Treatment. Toxins (Basel) 2021;13:132. [PMID: 33579040 DOI: 10.3390/toxins13020132] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Fatolahi H, Farahmand A, Rezakhani S; Department of Physical Education, Pardis Branch, Islamic Azad University, Pardis, Iran, Department of Physical Education, Central Tehran Branch, Islamic Azad University, Tehran, Iran, National Nutrition & Food Technology Research Institute, Shahid Beheshti University of Medical Sciences. The Effect of Caffeine on Health and Exercise Performance with a Cold Brew Coffee Approach: A Scoping Review. Nutr Food Sci Res 2020;7:1-12. [DOI: 10.29252/nfsr.7.2.1] [Reference Citation Analysis]
13 Lorenzi DS, Kovač MB, Koch V. Habits of Energy Drink Consumption among Teens in Slovenia - Focus Group Findings. Zdr Varst 2021;60:230-6. [PMID: 34917191 DOI: 10.2478/sjph-2021-0031] [Reference Citation Analysis]
14 Kouroumalis E, Voumvouraki A. Hepatitis C virus: A critical approach to who really needs treatment. World J Hepatol 2022; 14(1): 1-44 [DOI: 10.4254/wjh.v14.i1.1] [Reference Citation Analysis]
15 Carrieri P, Carrat F, Di Beo V, Bourlière M, Barré T, De Ledinghen V, Pageaux G, Bureau M, Cagnot C, Dorival C, Delarocque-astagneau E, Marcellin F, Pol S, Fontaine H, Protopopescu C, Laurent Alric, Bonnet D, Payssan-sicart V, Pomes C, Zoulim F, Maynard M, Bai R, Hucault L, Bailly F, Raffi F, Billaud E, Boutoille D, Lefebvre M, André-garnier E, Cales P, Hubert I, Lannes A, Lunel F, Boursier J, Asselah T, Boyer N, Giuily N, Castelnau C, Scoazec G, Pol S, Fontaine H, Rousseaud E, Vallet-pichard A, Sogni P, de Ledinghen V, Foucher J, Hiriart J, M’bouyou J, Irlès-depé M, Bourlière M, Si Ahmed SN, Oules V, Tran A, Anty R, Gelsi E, Truchi R, Thabut D, Hammeche S, Moussali J, Causse X, De Dieuleveult B, Ouarani B, Labarrière D, Ganne N, Grando-lemaire V, Nahon P, Brulé S, Ulker B, Guyader D, Jezequel C, Brener A, Laligant A, Rabot A, Renard I, Habersetzer F, Baumert TF, Doffoel M, Mutter C, Simo-noumbissie P, Razi E, Bronowicki J, Barraud H, Bensenane M, Nani A, Hassani-nani S, Bernard M, Pageaux G, Larrey D, Meszaros M, Metivier S, Bureau C, Morales T, Peron JM, Robic MA, Decaens T, Froissart B, Hilleret M, Costentin C, Gerster T, Riachi G, Goria O, Paris F, Montialoux H, Leroy V, Amaddeo G, Varaut A, Simoes M, Amzal R, Chazouillières O, Andreani T, Angoulevant B, Chevance A, Serfaty L, Duclos Vallée J, Samuel D, Antonini T, Coilly A, Tateo M, Abergel A, Reymond M, Brigitte C, Benjamin B, Muti L, Geist C, Conroy G, Riffault R, Rosa I, Barrault C, Costes L, Hagège H, Loustaud-ratti V, Carrier P, Debette-gratien M, Mathurin P, Lassailly G, Lemaitre E, Canva V, Dharancy S, Louvet A, Minello A, Latournerie M, Bardou M, Mouillot T, D’alteroche L, Barbereau D, Nicolas C, Elkrief L, Jaillais A, Gournay J, Chevalier C, Archambeaud I, Habes S, Portal I, Gelu-simeon M, Saillard E, Lafrance M, Catherine L, Carrat F, Chau F, Dorival C, Goderel I, Lusivika-nzinga C, Bellance M, Bellet J, Monfalet P, Chane-teng J, Bijaoui S, Pannetier G, Téoulé F, Nicol J, Bekhti R, Cagnot C, Boston A, Nailler L, Le Meut G, Diallo A, Petrov-sanchez V, Marc Bourlière, Boursier J, Carrat F, Carrieri P, Delarocque-astagneau E, De Ledinghen V, Dorival C, Fontaine H, Fourati S, Housset C, Larrey D, Nahon P, Pageaux G, Petrov-sanchez V, Pol S, Bruyand M, Wittkop L, Zoulim F, Zucman-rossi J, L’hennaff M, Sizorn M, Boston A, Diallo A, Cagnot C, Bousselet A, Caralp M. Severe liver fibrosis in the HCV cure era: major effects of social vulnerability, diabetes, and unhealthy behaviors. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100481] [Reference Citation Analysis]